Medical News

RSS

Kaiser Permanente wins 2015 CIO 100 Award for using health IT to improve quality and care delivery

Kaiser Permanente recently was honored by IDG's CIO magazine as one of the 2015 CIO 100 award winners for using technology to improve the health care experience for patients and their families.

16 Jun 2015

Updated March of Dimes CineMama app helps women to track their weight gain during pregnancy

Gaining too much or too little weight during pregnancy can have serious health consequences for your baby. The updated March of Dimes CineMama app helps moms-to-be track their weight gain as well as make a time-lapse movie of their pregnancy. The app is free and available for both iOS and android devices.

16 Jun 2015

Supplemental Health Care's Miamisburg, Ohio, operation named 2015 Best Employment Agency

Supplemental Health Care's Miamisburg, Ohio, operation has been named the "2015 Best Employment Agency" by a prestigious local program that honors local businesses for the use of innovative strategies to grow their organizations. Supplemental Health Care, a leader in healthcare staffing solutions, was recognized for its effective approach to marketing, customer service and community leadership.

16 Jun 2015

PNP Therapeutics granted FDA orphan drug designation for Gedeptin

PNP Therapeutics Inc. announced today the Food and Drug Administration has granted orphan drug status to Gedeptin, the Company's lead product candidate (adenoviral vector expressing E. coli purine nucleoside phosphorylase gene) for the intratumoral treatment of anatomically accessible oral and pharyngeal cancers, including cancers of the lip, tongue, gum, floor of mouth, salivary gland and other oral cavities.

16 Jun 2015

CyMedica Orthopedics closes $11.5 million Series A financing

CyMedica Orthopedics, Inc. announced today that it has closed an extension to its Series A financing. The Series A financing was led by investors Research Corporation Technologies, Inc., a Tucson-based venture capital firm, and California Technology Ventures, LLC, a Pasadena-based venture capital fund. The financing also included participation from existing investor Aphelion Capital (Mill Valley, CA) and the founding group of investors.

16 Jun 2015

Genticel’s GTL001 phase 1 clinical study of HPV therapeutic vaccine granted FDA clearance

Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel’s Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.

16 Jun 2015

Link between poverty and kidney disease changes over time, study finds

Poverty is known to be a strong risk factor for end-stage kidney disease. Now, a first of-its-kind study has found that the association between poverty and kidney disease changes over time.

16 Jun 2015

Only half of all Americans protected from secondhand smoke exposure

Many Americans view smoking, and secondhand smoke, as a problem that has mostly been solved, at least in the United States. However, only half of all Americans are protected from exposure to secondhand smoke, whether in public places or at work.

16 Jun 2015

FDA grants Fast Track designation to Juventas' JVS-100 drug candidate and allows Phase 2b clinical trial

Juventas Therapeutics, Inc., a clinical-stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body, today announced that its product candidate, JVS-100, received Fast Track designation from the U.S. Food and Drug Administration for the treatment of advanced ischemic chronic heart failure.

16 Jun 2015

New study on athletes’ immune function aims to prevent illness, optimize performance

With the Gold Coast Commonwealth Games looming in 2018, a key concern for athletes will be how to prevent illness from interfering with their training and performance.

16 Jun 2015

Apexigen initiates APX005M Phase 1 clinical trial in adults with solid tumors

Apexigen, Inc., a biopharmaceutical company discovering and developing innovative antibody drugs for the treatment of cancer and other life-threatening diseases, announced today the initiation of a Phase 1 clinical trial of APX005M, the company's lead proprietary anticancer program.

16 Jun 2015

Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications, today announced that it has entered into an exclusive license agreement with affiliates of Fagron NV for the commercialization of OMS103, Omeros' product for arthroscopic surgery.

16 Jun 2015

BiondVax invited to present at EDUFULVAC-NIAID workshop on immunoassay standardization for universal flu vaccines

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases,today announced that it has been invited to present in a workshop organized by EDUFULVAC, (EDUcate inFLUenza VACcine) a corresponding European Consortium coordinated by the European Vaccine Initiative (Germany) and NIAID (the National Instituteof Allergy and Infectious Diseases, a National Institute of Health branch) in the United States.

16 Jun 2015

Pulmatrix announces new inhaled anti-infective therapy to treat CF-associated fungal infections

Pulmatrix, Inc., a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today announced a new drug candidate, PUR1900, an inhaled anti-infective to treat fungal infections associated with cystic fibrosis (CF).

16 Jun 2015

Study highlights medical, health care challenges faced by African American lesbian or bisexual women

More than one third of African American lesbian or bisexual women reported a negative experience with a heathcare provider and many of those women did not seek medical care the next time they were ill, according to a study published in LGBT Health, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

16 Jun 2015

Althea obtains European GMP certificate from HPRA for commercial aseptic filling and testing

Ajinomoto Althea, Inc., a leading provider of biopharmaceutical contract development and manufacturing services announced today that it has officially received its European GMP certificate from the Health Products Regulatory Authority for commercial aseptic filling and testing.

16 Jun 2015

Pulmatrix completes previously announced merger and closes $10 million in private placement

Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.

16 Jun 2015

Pulmatrix signs ex-U.S. development agreement with Mylan for bronchodilator therapy

Pulmatrix, a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today announced that it has entered into an ex-U.S. development agreement with Mylan N.V., one of the world's leading global pharmaceutical companies.

16 Jun 2015

'Brain-to-Text' system decodes spoken speech and transforms it into textual representation

Speech is produced in the human cerebral cortex. Brain waves associated with speech processes can be directly recorded with electrodes located on the surface of the cortex. It has now been shown for the first time that is possible to reconstruct basic units, words, and complete sentences of continuous speech from these brain waves and to generate the corresponding text.

16 Jun 2015

MedUni Vienna uses new MR technique to classify adenomas

Adenomas are rare liver tumours, a certain percentage of which can become malignant. Using a new MR (magnetic resonance) technique at MedUni Vienna, it is now possible to classify adenomas without subjecting patients to invasive tissue sampling procedures.

16 Jun 2015

Medical News

Kaiser Permanente wins 2015 CIO 100 Award for using health IT to improve quality and care delivery

Updated March of Dimes CineMama app helps women to track their weight gain during pregnancy

Supplemental Health Care's Miamisburg, Ohio, operation named 2015 Best Employment Agency

PNP Therapeutics granted FDA orphan drug designation for Gedeptin

CyMedica Orthopedics closes $11.5 million Series A financing

Genticel’s GTL001 phase 1 clinical study of HPV therapeutic vaccine granted FDA clearance

Link between poverty and kidney disease changes over time, study finds

Only half of all Americans protected from secondhand smoke exposure

FDA grants Fast Track designation to Juventas' JVS-100 drug candidate and allows Phase 2b clinical trial

New study on athletes’ immune function aims to prevent illness, optimize performance

Apexigen initiates APX005M Phase 1 clinical trial in adults with solid tumors

Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

BiondVax invited to present at EDUFULVAC-NIAID workshop on immunoassay standardization for universal flu vaccines

Pulmatrix announces new inhaled anti-infective therapy to treat CF-associated fungal infections

Study highlights medical, health care challenges faced by African American lesbian or bisexual women

Althea obtains European GMP certificate from HPRA for commercial aseptic filling and testing

Pulmatrix completes previously announced merger and closes $10 million in private placement

Pulmatrix signs ex-U.S. development agreement with Mylan for bronchodilator therapy

'Brain-to-Text' system decodes spoken speech and transforms it into textual representation

MedUni Vienna uses new MR technique to classify adenomas

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News